SANOFI CONS HEALTHC IND L (SANOFICONR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has a cash flow conversion efficiency ratio of 0.409x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.57 Billion ≈ $16.97 Million USD) by net assets (Rs3.84 Billion ≈ $41.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of SANOFI CONS HEALTHC IND L for the company's overall valuation and market capitalisation.
SANOFI CONS HEALTHC IND L - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how SANOFI CONS HEALTHC IND L's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SANOFI CONS HEALTHC IND L Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their cash flow conversion efficiency. Explore SANOFI CONS HEALTHC IND L earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Charoen Pokphand Enterprise Taiwan Co Ltd
TW:1215
|
0.048x |
|
JiangSu Jin Tong Ling Fluid Mach
SHE:300091
|
-0.044x |
|
Verve Therapeutics Inc
NASDAQ:VERV
|
-0.059x |
|
Max Zipper Co Ltd
TWO:8932
|
0.110x |
|
Cosmo Pharmaceuticals N.V
F:C43
|
0.013x |
|
CBL & Associates Properties Inc
NYSE:CBL
|
0.204x |
|
Troax Group AB
ST:TROAX
|
-0.014x |
|
Guangxi Guidong Eletric Power Co Ltd
SHG:600310
|
0.050x |
Annual Cash Flow Conversion Efficiency for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual cash flow conversion efficiency of SANOFI CONS HEALTHC IND L from 2023 to 2025. View SANOFICONR live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rs3.84 Billion ≈ $41.53 Million |
Rs1.88 Billion ≈ $20.33 Million |
0.490x | -69.55% |
| 2024-12-31 | Rs2.73 Billion ≈ $29.52 Million |
Rs4.39 Billion ≈ $47.48 Million |
1.608x | +83558.24% |
| 2023-12-31 | Rs2.08 Billion ≈ $22.45 Million |
Rs-4.00 Million ≈ $-43.26K |
-0.002x | -- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more